4kp6: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "4kp6" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
{{STRUCTURE_4kp6| PDB=4kp6 | SCENE= }} | |||
===Crystal structure of human phosphodiesterase 4B (PDE4B) in complex with a [1,3,5]triazine derivative=== | |||
{{ABSTRACT_PUBMED_23806553}} | |||
==Function== | |||
[[http://www.uniprot.org/uniprot/PDE4B_HUMAN PDE4B_HUMAN]] Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in mediating central nervous system effects of therapeutic agents ranging from antidepressants to antiasthmatic and anti-inflammatory agents.<ref>PMID:10846163</ref> <ref>PMID:15003452</ref> | |||
==About this Structure== | |||
[[4kp6]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4KP6 OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:023806553</ref><references group="xtra"/><references/> | |||
[[Category: 3',5'-cyclic-nucleotide phosphodiesterase]] | |||
[[Category: Homo sapiens]] | |||
[[Category: Egerland, U.]] | |||
[[Category: Gewald, R.]] | |||
[[Category: Grunwald, C.]] | |||
[[Category: Copd]] | |||
[[Category: Hydrolase-hydrolase inhibitor complex]] | |||
[[Category: Neutrophilia]] | |||
[[Category: Pde4 inhibitor]] | |||
[[Category: Phosphodiesterase]] | |||
[[Category: Triazine]] | |||
Revision as of 15:38, 10 July 2013
Crystal structure of human phosphodiesterase 4B (PDE4B) in complex with a [1,3,5]triazine derivative
Template:ABSTRACT PUBMED 23806553
Function
[PDE4B_HUMAN] Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in mediating central nervous system effects of therapeutic agents ranging from antidepressants to antiasthmatic and anti-inflammatory agents.[1] [2]
About this Structure
4kp6 is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Gewald R, Grunwald C, Egerland U. Discovery of triazines as potent, selective and orally active PDE4 inhibitors. Bioorg Med Chem Lett. 2013 Aug 1;23(15):4308-14. doi: 10.1016/j.bmcl.2013.05.099., Epub 2013 Jun 10. PMID:23806553 doi:10.1016/j.bmcl.2013.05.099
- ↑ Xu RX, Hassell AM, Vanderwall D, Lambert MH, Holmes WD, Luther MA, Rocque WJ, Milburn MV, Zhao Y, Ke H, Nolte RT. Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity. Science. 2000 Jun 9;288(5472):1822-5. PMID:10846163
- ↑ Xu RX, Rocque WJ, Lambert MH, Vanderwall DE, Luther MA, Nolte RT. Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram. J Mol Biol. 2004 Mar 19;337(2):355-65. PMID:15003452 doi:https://dx.doi.org/10.1016/j.jmb.2004.01.040